Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1734-1742

  Falk, Sigrid ^b   Göggel, Rolf ^b   Heydasch, Ulrich ^b   Brasch, Frank ^b   Müller, Klaus Michael ^b   Wendel, Albrecht ^b   Uhlig, Stefan ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ACETYLSALICYLIC ACID; CHLOROQUINE; DOCEBENONE; QUINIDINE; QUININE; QUINOLINE DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR;

AIRWAY RESISTANCE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAVASATION; FEMALE; ISOLATED LUNG; LUNG EDEMA; LUNG PERFUSION; MALE; MOUSE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0345149046     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9902033     Document Type: Article

References (42)

1. Carter, M. B., M. A. Wilson, W. B. Wead, and R. N. Garrison. 1996. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia reperfusion. J. Surg. Res. 60:403-408.
2. Chung, K. F. 1992. Platelet-activating factor in inflammation and pulmonary disorders. Clin. Sci. 83:127-138.
3. Rodriguez-Roisin, R., M. A. Félez, K. F. Chung, J. A. Barbera, P. D. Wagner, A. Cobos, P. J. Barnes, and J. Roca. 1994. Platelet-activating factor causes ventilation-perfusion mismatch in humans. J. Clin. Invest. 93:188-194.
4. Uhlig, S., R. Nüsing, A. von Bethmann, R. L. Featherstone, T. Klein, F. Brasch, K.-M. Müller, V. Ullrich, and A. Wendel. 1996. Cyctooxygenase-2 dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol. Med. 2:373-383.
5. Uhlig, S., L. Wollin, and A. Wendel. 1994. Contributions of thromboxane and Ieukotrienes to platelet-activating factor-induced impairment of lung function in the rat. J. Appl. Physiol. 77:262-269.
6. Chang, S. W., C. O. Feddersen, P. M. Henson, and N. F. Voelkel. 1987. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-trealed rats. J. Clin. Invest. 79:1498-1509.
7. Garcia, M. L. B., P. S. O. Paiva, M. Dolhnikoff, S. Jancar, P. H. N. Saldiva, and M. A. Martins. 1994. Airway and pulmonary tissue responses to platelet-activating factor in rats. Exp. Lung Res. 20:169-184.
8. Rabinovici, R., M. D. Sofronski, J. F. Renz, L. M. Hillegas, K. M. Esser, J, Vernick, and G. Feuerstein. 1992. Plaetelet activating factor mediates interleukin-2-induced lung injury in the rat. J. Clin. Invert. 89:1669-1673.
9. Moore, T. M., P. L. Khimenko, and A. E. Taylor. 1995. Restoration of normal pH triggers ischemia-reperfusion injury in lung by Na+/H+ exchange activation. Am. J. Physiol. 269:H1501-1505.
10. Boschetto, P., D. F. Rogers, L. M. Fabbri, and P. J. Barnes. 1991. Corlicosteroid inhibition of airway microvascular leakage. Am. Rev. Respir. Dis. 143:605-609.
11. Ortiz, J. L., J. M. Vallés, M. Martí-Cabrera, J. Cortijo, and E. J. Morcillo. 1996. Effects of selective phosphodicstcrase inhibitors on platelet-activating factor and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs. Naunyn-Schmiedebergs Arch. Pharmacol. 353:200-206.
12. Chen, S. F., and Y. J. Ruan. 1995. 1 alpha,25-dihydroxyvitamin D3 decreases scalding and platelet-activating factor-induced high vascular permeability edema. Pharmacol. Toxicol. 76:365-367.
13. Huang, Y.-C., T. P. Kennedy, Y.-F. Su, W. D. Watkins, A. R. Whorton, and C. A. Piantadosi. 1993. Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung. J. Appl. Physiol. 74:251-258.
14. Hocking, D., T. J. Ferro, and A. Johnson. 1992. Dextran sulfate and heparin inhibit platelet-activating factor-induced pulmonary edema. J. Appl. Physial. 72:179-185.
15. Charous, B., B. Halpern, and G. Steven. 1998. Hydroxychloroquine improves airflow and lower circulating IgE levels in subjects with moderate symptomatic asthma. J. Allergy Clin. Immunol. 102:198-203.
16. Uhlig, S., and L. Wollin. 1994. An improved setup for the isolated perfused rat lung. J. Pharmacol. Toxicol. Methods 31:85-94.
17. Uhlig, S. 1998. The isolated perfused lung. In S. Uhlig and A. E. Taylor, editors. Methods in Pulmonary Pharmacology. Birkhäuser, Basel. 29.
18. Uhlig, S., and O. Heiny. 1995. Measuring the weight of the isolated perfused rat lung during negative pressure ventilation. J. Pharmacol. Toxicol. Methods 33:147-152.
19. Drake, R., K. A. Gaar, and A. E. Taylor. 1978. Estimation of the filtration coefficient of pulmonary exchange vessels. Am. J. Physiol. 234:H266-H274.
20. Uhlig, S., and A. N. von Bethmann. 1997. Determination of vascular compliance, interstitial compliance and capillary filtration coefficient in isolated perfused rat lungs. J. Pharmacol. Toxicol. Methods 32:119-127.
21. Dawson, C. A., S. H. Audi, and J. H. Linchan. 1998. Segmental vascular resistance and compliance obtained from vascular occlusion. In S. Uhlig and A. E. Taylor, editors. Methods in Pulmonary Research. Birkhäuser, Hasel. 135.
22. Rogers, D. F., P. Boschetto, and P. J. Barnes. 1989. Correlation between Evens Blue dye and radiolabeled albumin in guinea pig airways in vivo. Pharmacol. Methods 21:309-315.
23. Wright, S. P. 1992. Adjusted P-values for simultaneous interference. Biometrics 48:1005-1013.
24. Lantz, R. C., G. E. Keller, and R. Burrell. 1991. The role of platelet-activating factor in the pulmonary response to inhaled endotoxin. Am. Rev. Respir. Dis. 144:167-172.
25. Sirois, M. G., G. E. Plante, P. Braquet, and P. Sirois. 1990. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. Br. J. Pharmacol. 101:896-900.
26. Tavares de Lima, W., F. H. Kwasinieswki, F. Sirois, and S. Jancar. 1995. Studies on the mechanism of PAF-induced vasopermeability in rat lungs. Prostaglandins Leukot. Essent. Fatty Acids 52:245-249.
27. Noel, P. E., J. R. Fletcher, and W. J. Thompson. 1995. Rolipram and isoproterenol reverse platelet activating factor-induced increases in pulmonary microvascular permeability and vascular resistance. J. Surg. Res. 59:159-164.
28. Moore, T. M., P. M. Chetham, J. J. Kelly, and T. Stevens. 1998. Signal transduction and regulation of lung endothelial cell permeability: interaction between calcium and cAMP. Am. J. Physiol. 275:L203-L222.
29. Ortiz, J. L., J. Cortijo, J. M. Valles, J. Bon, and E. J. Morcillo. 1992. Rolipram inhibits PAF-induced airway microvascular leakage in guinea-pig: a comparison with milrinone and theophylline. Fundam. Clin. Pharmacol. 6:247-249.
30. Van Renterghem, C., P. Vigne, and C. Frelin. 1995. A charybdotoxinsensitive, Ca(2+)-activated K+-channel with inward rectifying properties in brain microvascular endothelial cells: properties and activation by endothelins. J. Neurnchem. 65:1274-1281.
31. Misra, U. K., G. Gawdi, and S. V. Pizzo. 1997. Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5-trisphosphate binding to its receptor. J. Cell. Biochem. 64:225-232.
32. List, A. F. 1996. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10:937-942.
33. Kench, J. G., J. P. Scale, D. M. Temple, and C. Tennant. 1985. The effects of non-steroidal inhibitors of phospholipase A2 on Ieukotriene and histamine release from human and guinea-pig lung. Prostaglandins 30:199-208.
34. Portanova, J. P., Y. Zhang, G. D. Anderson, S. D. Hauser, J. L. Masferrer, K. Seibert, S. A. Gregory, and P. C. Isakson. 1996. Selective neutralization of proslagandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 184:883-891.
35. Horgan, M. J., G. P. Palace, J. E. Everitt, and A. B. Malik. 1993. TNF-alpha release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am. J. Physiol. 264:H1161-H1165.
36. Gatti, S., R. Faggioni, B. Echtenacher, and P. Ghezzi. 1993. Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary edema and lethality. Clin. Exp. Immunol. 91:456-461.
37. Ronsignore, M. R., A. Valenti, and M. Spatafora. 1992. Tumor necrosis factor-alpha does not cause lung edema in rabbits. J. Appl. Physiol 73:173-178.
38. Stephens, K. E., A. Ishizaka, J. W. Larrik, and T. A. Raffin. 1988. Tumor necrosis factor causes increased pulmonary permeability and edema. Am. Rev. Respir. Dis. 137:1364-1370.
39. Jesmok, G., C. Lindsey, M. Duerr, M. Fournel, and T. Emerson. 1992. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coll-challenged swine. Am. J. Pathol. 141:1197-1207.
40. Maruyama, N., Y. Kakuta, K. Yamauchi, Y. Ohkawara, T. Aizawa, T. Ohrui, M. Nara, T. Oshiro, I. Ohno, G. Tamura, S. Shimura, H. Sasaki, T. Takishima, and K. Shirato. 1994. Quinine inhibits production of tumor necrosis factor-α from human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 10:514-520.
41. Gantner, F., S. Uhlig, and A. Wendel. 1995. Quinine inhibits release of tumor necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure. Eur. J. Pharmacol. 294:353-355.
42. Doyle, V. M., J. A. Creba, and U. T. Rüegg. 1986. Platelet activating facor mobilises intracellular calcium in vascular smooth muscle cells. FEBS Lett. 197:13-16.